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ABSTRACT
Down syndrome  (DS) is a genetic  disorder  caused  by the trisomy of chromosome  21 in humans.
Almost all individuals  with DS also  experience  an  early onset  of Alzheimer's  disease  (AD) and
show  similar cognitive  and  learning  deficits.  There  are  currently  no treatments  for these  deficits
in DS. However,  choline  availability during the  perinatal  period  has  shown  to have  long-term
benefits  on memory  and  attentional  function.  This study  utilized a series  of attentional  tests  that
evaluated  the benefits  of perinatal  choline  treatment  in Ts65Dn  mice,  an  animal  model  of Down
syndrome.  Specifically,  we used  the "Surprising  Reward  Omission"  (SRO)  Task  in which an
expected  reward  is omitted  on 20% of the correct  responses,  to test  attentional  dysfunction  and
heightened  error reactivity in these  mice.  Since  previous  SRO  studies  with Ts65Dn  mice have
shown  an  increase  in locomotor  activity and  stereotypic  behaviors  such  as  jumping and
grooming  following reward  omission,  we supplemented  our findings on overall performance
with an analysis  of video data We hypothesized  that  the  Ts65Dn  mice will exhibit an
exaggerated  response  to the omission  of an  expected  reward  relative  to controls,  which will be
reflected  by their poor  performance  on the SRO  task,  and  that  choline  treatment  will alleviate
these  dysfunctions.  Our results  indicated  that the unsupplemented  Ts65Dn  mice had  significant
attentional  dysfunction  and  reacted  to incorrect  responses  with increased  activity level. These
abnormalities  in Ts65Dn  mice  were  normalized  by perinatal  choline  supplementation.  The
reward  omission  did not significantly affect  the  performance  of any  of the mice (in terms  of
correct  responses).  Yet the elevated  alcove  latencies  and  omission  errors  in unsupplemented
Ts65Dn  mice provided  some  indication  of increased  reaction  to reward  omission.  We expect  the
behavioral  video analysis  (in progress)  to elucidate  the  exact  nature  of these  reactions  and  the
effect of choline  treatment  on arousal  regulation  and  subsequent  behaviors  in Ts65Dn  mice.2 Assessment  of the Effects of Perinatal Choline Treatment
INTRODUCnONANDBACKGROUND
Down Syndrome
Down syndrome  (DS) is a genetic  disorder  caused  by the trisomy of chromosome  21 in
humans.  It is the most  common  form of mental  retardation  with a known genetic  basis.
Individuals  with DS have  neuropathological  abnormalities  such  as  reduction  in neuronal  density,
dendritic  spine  development,  and  synaptic  function (Sea  et al., 2005). Almost all individuals
with DS also  experience  an  early onset  of Alzheimer's Disease  (AD). The pattern  of cognitive
decline  and  neuropathology  seen  in both disorders  are  very similar. They include  cognitive  and
learning  deficits, attention  deficits,  and  pathology  such  as  neuritic plaques  and  neurofibrillary
tangles  (Salehi  et al., 2006)
A prominent  neuropathological  feature  in both  DS and  AD is atrophy  of basal  forebrain
cholinergic  neurons  (BFCNs),  which provide  the cholinergic  innervation  to the hippocampus  and
the  cortex  (Villar et aI., 2005;  Hunter  et aI.,  2003). The frontal cortex  is thought  to be
responsible  for working memory  and  executive  functions  and  the BFCNs  playa key role in
regulating  these  cognitive and  attentional  processes  in both animals  and  humans  (Kasa  et al
1997). Similarly, in both humans  and  animals,  the hippocampus  subserves  declarative  or explicit
memory  function.  Therefore,  the impairments  in memory  and  attentional  function seen  in DS is
believed  to be due  to the atrophy  of the  BFCN that  project,  respectively,  to the hippocampus  and
frontal cortex  (Driscoll et aI.,  2004;  Hyde  et aI.,  2001).
Ts65Dn mice
There  are  currently  no treatments  that can  improve  cognitive  functioning  in DS,
However,  the  recent  development  of mouse  models  of DSmay enable  the development  of
effective  therapies The  best  available  mouse  model,  the Ts65Dn  mouse.  is trisomic for a oortion3 Assessment  of the Effects of Perinatal Choline Treatment
of chromosome  16,  which contains  many  of the genes  that are  on chromosome  21 in humans,
including the so-called  "Down syndrome  critical region" (Holtzman  et al., 1996).  These  mice
also  exhibit many  of the key features  of DS, notably  including deficits in learning,  attention,  and
memory  (Contestabile  et aI.,  2006; Driscoll et aI., 2004;  Crnic & Pennington,  2003).  Like
humans  with DS, these  mice are  born with an  intact cholinergic  basal  forebrain  but show
degeneration  by 6 months  of age  (Holtzman  et aI., 1996). Importantly,  with age,  these  mice
show  declines  in explicit memory  and  attention,  functions  dependent  on the two projection
systems  of the basal  forebrain  cholinergic  system  (Driscoll et al., 2004,)
A previous  study  in our lab has  validated  the use  of TS65Dn  mice to study  both DS and
AD. First, this study  provided  the first evidence  that Ts65Dn  mice,  like DS humans,  exhibit
attentional  dysfunction.  (Driscoll et al., 2004).  This study  also  revealed  that TS65Dn  mice
exhibit  a  heightened  emotional  response  to  committing  an  error,  indicated  by  stereotypic
.
jumping and  grooming  specifically  on post-error  trials (Driscoll et al., 2004)
Mechanism  for neural degeneration
Recent  studies  have  shed  light on the mechanism  underlying  the atrophy  of BFCN's in
os. BFCN's are  dependent  on neurotrophins  such  as  NGF for development  and  maintenance  of
function (Hunter  et aI.,  2003). There  is a decline  in the function of neurotrophins,  including
nerve  growth factor (NGF), in both DS and  AD (Sendera  et aI.,  2000). NGF is a target-derived
neurotrophic  factor that is very important  for the survival,  differentiation,  and  maintenance  of
BFCNs  (Salehi  et al., 2006).  It is normally produced  and  retrogradely  transported  from the
hippocampus  and  cerebral  cortex  to the  cholinergic  cell bodies  in the  basal  forebrain  (Granholm
et al., 2000). Recent  studies  with the  Ts65Dn  mouse  have  demonstrated  that the atrophy  of
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to the  cell bodies  (Cooper  et aI., 200  1; Salehi  et aI., 2006).  The  importance  of NGF in
maintaining  BFCN function is supported  by the discovery  that transgenic  mice  producing  NGF
anti-bodies  have  severe  age-related  BFCN degeneration  and  that direct,  intracerebral  injection of
NGF to cell bodies  reversed  the atrophy  of BFCNs  in the  Ts65Dnmouse  (Capsoni  et aI., 2000;
Cooper  et aI., 2001). Furthemlore,  a recent  study  (Salehi  et aI., 2006)  demonstrated  that this
impaired  retrograde  transport  of NGF in cholinergic  neurons  in the  Ts65Dn  mouse  is due  to
trisomy of the gene  that codes  for the amyloid  precursor  protein  (APP),  a protein  that has  long
been  implicated  in AD pathogenesis  in humans  (Hunter  et aI., 2003;  Seo  et aI., 2005).  The gene
that codes  for APP is found  on chromosome  21 in humans  (and  chromosome  16  in mice).
Deletion  of a copy of APP in Ts65Dn  mice (nonnally trisomic for this gene)  has  been  shown  to
result  in improved  NGF transport  and  BFCN morphology  (Salehi  et aI., 2006)
Choline
Recent  studies  suggest  that  improved  cognitive  function in DS might be achieved  by
supplementation  with excess  choline  during  pregnancy  and  early  postnatal  life. Choline
(trimethyl-beta-hydroxy-ethylammonium)  is an  essenti~  nutrient  in humans.  It serves  as  a
precursor  to components  of biological membranes,  is involved  in fat metabolism  in the liver, is a
source  of biologically labile methyl groups,  is a precursor  of signaling  lipids, and  is the  precursor
to the neurotransmitter  acetylcholine  (McCann  et aI.,  2006).  Of particular  relevance  for Down
syndrome,  choline  availability during the perinatal  period  is related  to lifelong variations  in
memory  and  attentional  function,  putatively  due  to organizational  effects  on the  cholinergic
system  (reviewed  in Williams and  Meck, 2003). Finally, the evidence  for neuroprotective  effects
(reviewed  below) provides  encouragement  that  this type  of intervention  might offer protection
against  degenerative  process  that occurs  with the onset  of AD.5 Assessment  of the Effects of Perinatal Choline Treatment
The hypothesis  that perinatal  choline  supplementation  may  improve  cognitive
functioning  in DS is based  on the fact that the cognitive  dysfunction  in DS pertains  primarily to
functions  dependent  on BFCN's (reviewed  above),  and  the  evidence  of effects  produced  by early
nutritional manipulation  in normal  rats  and  mice.  Specifically,  choline  supplementation  of the
dam's  drinking water  during gestation  and/or  lactation  has  been  shown  to produce  many  lasting
beneficial  behavioral  and  neural  changes  in the offspring.  For instance,  dietary  choline
supplementation  during a brief, critical period  of prenatal  development  improves  explicit
memory  functions  mediated  by the septohippocampaI  system.  (Meck et aI., 2003;  Li et aI., 2004).
There  are  also  long-term  changes  in cholinergic  activity, evinced  by altered  levels  of
acetylcholinesterase  (AChE) choline  acetyltransferase  (ChAT), increased  hippocampal
responsiveness  to cholinergic  stimulation,  and  increased  size  of CBFneurons  (Guo-Ross  et al.,
2002;  Mohler et al., 2001,  Pyapali  et al., 1998).  Prenatal  choline  supplementation  has  also  been
shown  to improve  performance  ofnonnal mice  in a visual attention  task,  implying that early
choline  availability alters  not only the CBF projections  to the hippocampus,  but those  to the
frontal cortex  as  well (Mohler et al., 2001).  Choline  supplementation  during early development  is
thought  to organize  the  brain so  that it has  more 'cognitive reserve'  that can  be used  as  the  brain
ages  and  loses  connectivity  (Meck et aI.,  2003)
Other  studies  have  shown  that supplementation  with choline  during the  perinatal  period
has  long-lasting  neuroprotective  effects. Choline  supplementation  to pregnant  dams  during a 6
day  period  during gestation  showed  decreased  MK801-induced  neurodegeneration  in posterior
cingulate  and  retrosplenial  cortex  sections  in both adult  males  and  females  postnatally  (Guo-Ross
et aI.,  2002).  Offspring of choline  supplemented  dams  also  showed  an increase  in hippocampal
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in light of the  evidence  that impaired  NGF function  plays  a pivotal role in the atrophy  of BFCN's
in the  Ts65Dn  mouse  model  of DS (Cooper  et aI.,  2001;  Salehi  et al., 2006),  as  noted  above.
For the above  reasons,  we hypothesize  that  perinatal  choline  supplementation  will
improve  cognitive  functioning  in Ts65Dn  mice; the present  study  is designed  to test  this
This hypothesis  will be tested  using  the series  of attentional  tests  that previously hypothesis
showed  attentionaI  dysfunction  and  heightened  error reactivity in Ts65Dn  mice (Driscoll et aI.,
2004). In addition,  a new task  will be included  to further  explore  the  putative  impairment  in the
regulation  of emotion  or arousal  in Ts65Dn  mice and  assess  whether  this area  of impairment  in
This task,  called  the "Surprising  Reward alleviated  by perinatal  choline  supplementation.
Omission"  (SRO)  Task,  is a test  of attentional  function-in  which an  expected  reward  is omitted
on 20%  of the  correct  responses.  Previous  studies  using  the SRO  task  for rats  have  shown  that
animals  respond  to reward  omissions  with an  increased  number  of nontrials  (failing to initiate a
trial) or incorrect  responses  in the following trials (Papini  et al., 1997).  SRO  studies  have  also
shown  an increase  in locomotor  activity following reward  omission,  an  effect that may  be
exacerbated  in Ts65Dn  mice,  based  on some  prior evidence  that  they are  hyperactive  under  some
circumstances  (Papini  et aI., 1997;  Siarey  et aI. 1997: To assess  this putative  effect,  we will
measure  activity level, based  on coding  of videotapes  of the mice  performing  this task.  It is
hypothesized that the trisomic mice will  exhibit an exaggerated  response  to the omission of an
expected reward. relative to controls. as evidenced by poorer perfonnance and/or increased
activity on trials following  a reward omission or an error. Furthermore we hypothesize that this
area  of dysfunction will  be alleviated by perinatal choline treatment.
rhe present study was designed to test this hypothesis, using the Ts65Dn mouse model of
DS and AD.  HaIf of the Ts65Dn mice and 2N littermate controls were provided with excess7 Assessment  of the Effects of Perinatal Choline Treatment
dietary  choline  during gestation  and  lactation,  via supplementation  of the maternal  water  supply.
The  remaining  dams  were  not provided  with excess  choline  but were  maintained  on standard
rodent  chow formulated  to provide  sufficient  choline  intake.  The choline  intake  of the
supplemented  darns  was  approximately  4.5 times  that of the unsupplemented  darns,  within the
range  of dietary  variation  observed  in the human  population  (Li et aI.,  2004);
MATERIALS AND METHODS
S@iects
Fifty-five male  mice served  as  subjects  in this study. They were  bred  at the University  of
Colorado  Health  Sciences  Center  from stock  obtained  from Jackson  Laboratory  (Bar Harbor,
ME). The segmental  trisomy must  be maintained  on a segregating  genetic  background  whereby
females  positive  for the extra  segment  of chromosome  16  are  crossed  to male  Fl  hybrids  of
C57BL6J/Ei  and  C3H/HeJ.
Treatment Groups and Choline Supplementation
Subjects  were  divided into four different groups:  Ts65Dn  and  controls  that received
perinatal  choline,  and  Ts65Dn  and  controls  that did not receive  any  choline  supplementation.
Researchers  were  blinded  to the identity of the mice.
Upon  verification of insemination,  the pregnant  dams  were  randomly  allocated  to one  of
the tWo  concentrations  of choline  chloride  in the drinking water  (0 or 25 mM), which was
provided  ad libitum. The 25 roM choline  chloride  concentration  is the accepted  standard
treatment  in this literature  and,  as  reviewed  above,  has  been  shown  to produce  lifelong
improvements.  Both groups  had  unlimited access  to standard  rodent  chow (NIH 5K67;
Richmond,  St. Louis, MO). This regimen  continued  until the pups  were  weaned  at post-natal  day
21. After weaning,  the  pups  were  given  normal  food and  water.8 Assessment  of the Effects of Perinatal Choline Treatment
At weaning,  one  male  trisomic pup and  one  male  2N control were  selected  from each
The sample  size  for each  of litter to participate  in the  behavioral  testing  at Cornell University.
the four treatment  conditions  was:  (1) Ts65Dn  mice supplemented  with choline  perinatally
(n=10),  (2) Ts65Dn  mice not supplemented  with choline  (n=15).  (3) disomic  2N littermate
controls  supplemented  with choline  perinatally  (n=20),  and  (4) disomic  2N controls  not
supplemented  with choline  (0=  10).  Before  shipment  to Cornell,  the mice  were  genotyped  for the
extra  chromosome  and  for the  gene  causing  retinal degeneration.  Animals homozygous  for the
retinal degeneration  mutation  were  excluded  from the study.
At Cornell University  the mice were  individually housed  in plastic  polycarbonate  cages
and  were  given  food and  water  ad  libitum for the first few days.  Single  housing  was
implemented  to prevent  fighting, which often occurs  for male  mice,  when  they are  removed  daily
for behavioral  testing.  They were  maintained  on a reversed  12-h  light- 12-h  dark  cycle (lights on
at 18:00  h) in a humidity- and  temperature-controlled  environment.
Qk!
Animals  were  weighed  on a daily basis  and  fed standard  rodent  chow (ProLab  1000;
Purina  Mills, Richmond,  IN). In order  to maintain  motivation  to perform  in the operant  tasks,
their weights  were  gradually  reduced  to 80-85%  of their ad  libitum body weights,  and  then
maintained  at that level by limiting their daily food intake.  After each  testing  session,  their daily
ration of food was  calculated  by subtracting  the caloric value  of the liquid diet rewards  they had
received  during that day's test  sessions  (AIN-76A sweetened  purified chow; Bio-Serv,
Frenchtown,  NJ) from their total daily ration.9 Assessment  of the Effects of Perinatal Choline Treatment
All procedures  were  approved  by the Institutional  Animal Care  and  Use  Committee  at Cornell
University,  and  adhere  to the  National  Institutes  of Health's  (1986)  Guidefor the Care  and Use
of Laboratory Animals.
Testing Apparatus
Testing  was conducted  6 days  per week.  The 6
testing  chambers were  modified  from  the
dipper
operant chambers  developed  by  Humby and
colleagues  to assess  attention  in mice (Hurnby,
r.esponse  ports
Laird,  Davies,  & Wilkinson, 1999). Each
chamber situated inside sound was a
attenuating,  ventilated exterior chamber (see
Driscoll et al. 2004). One of the walls of each chamber  contained  5 circular ports (1 cm in
diameter,  2 cm above  the floor, and 5 rnrn apart)  which could each  be illuminated. In all of the
tasks administered in this experiment, one of these five  ports was illuminated  on each trial;  the
correct response  was a nose  poke into the illuminated port. Responses  into these  ports were
detected  by infrared photodiodes  positioned inside each port 0.5 cm from the opening. The
slightly recessed  panel (alcove) on the opposite wall  allowed access  to  a 0.01 ml  reward
dispensed  by the dipper. Infrared diodes were also used in the alcove to monitor head entries. A
thin metal door, controlled by a motor located outside of the testing chamber, provided access  to
the alcove.  A nose poke in the alcove was required to initiate a trial.  All  automated events in the
chamber were timed and controlled by PC programs written in BASIC.
A wide angle infrared video camera was mounted on top of each chamber and aimed
directly over the center of the box.  Each camera was connected to an external VCR andAs..~essment  of the Effects of Perinatal Choline Treatment  10
television screen  in order to monitor the activities of the animals and to record each session  on
videotape for further analysis. An LED board was also located outside the chamber, but still
within  view of the camera, in order to provide cues to facilitate videotape coding.
Behavioral  Testin.l?
Training for the series  of visual attention  tasks  began  at 6 months  of age. Testing  on the
Surprise  Reward  Omission  Task,  the focus  of this thesis  was  conducted  at approximately  11-12
The number  of animals  tested  in each  automated  chamber  was  balanced  by months  of age.
treatment  group. All testing  was  conducted  by individuals  blind to the genotype  and  choline
treatment  condition  of the animals.
A) Training
The mice flfSt progressed  through  a series  of four training stages  designed  to familiarize
the animals  with the testing  chamber  and  the sequence  of responses  necessary  to complete  a trial
for the visual  attention  tasks.  Briefly, the mice learned  that  the door to the dipper  alcove  would
be raised  at the start  of each  trial and  that a nose  poke  into the dipper  port, followed by a nose
poke  into one  of the five response  ports,  would produce  the  delivery of 0.04 ml of the liquid diet
in the  dipper  alcove. The  characteristics  of each  training stage  are  presented  below. These  four
training phases  were  mastered  in approximately  8-10 sessions.
In phase  1,  the mouse  learned  to obtain  a food reward  (0.04  mL of liquid diet) in the
dipper  alcove.  The alcove  door.  was  left open  for the  entire  50-trial session  and  each  nose
poke  in the dipper  alcove  was  rewarded  with reinforcement  for 5 seconds.
In phase  2, the mouse  was  habituated  to the opening  and  closing  of the alcove  door. The 2.
mouse  learned  that the opening  of the  door signaled  the availability of reward,  and  that
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before  the door  reopened  and  the next reward  was  available  This training had  a minimum
criterion of 50 trials.
In phase  3, the mouse  learned  the sequence  of events  that constituted  a trial. In this phase 3.
a food reinforcement  was  delivered  into the  dipper  alcove  only if the mouse  first initiated
a nose  poke  into the dipper  to initiate the  trial and  then  turned  around  and  made  a nose
poke  into any  of the 5 ports  on the  opposite  wall. The mouse  moved  to the next stage
once  it had  completed  50 trials within one  30 minute  session.
Phase  4 was  designed  to eliminate  port bias  and  provide  equal  experience  with each  of 4.
the ports.  During each  session,  4 of the 5 ports  were  blocked,  forcing the animals  to make
a nose  poke  in the only open  port. This was  done  for each  of the five ports,  in succession,
until the mouse  made  50 nose  pokes  into each  pQrt. This phase  therefore  required  a
minimum of five sessions.
B) Visual  Discrimination Task
After completing  training, the animals  were  tested  on a flve-choice  visual discrimination
tasks.  The onset  of a trial was  marked  by the opening  of the metal  door,  allowing the animal  a
chance  to initiate the trial by making  a nose  poke.  Immediately  after  trial initiation one  of the
five port LEDs was  illuminated  and  the  mouse  was  rewarded  for making  a nose-poke  into the
illuminated  port (correct  response).  The port remained  illuminated  for 32 seconds  or until the
mouse  made  a response.
A 5-second  timeout  period (signaled  by the illumination of a 2-W house  light on the
ceiling of the  chamber)  and  the unavailability  of reward  were  imposed  after  an  error (nose  poke
into a port that  was  not illuminated).  A "nontrial", which occurred  when  the animal  failed to
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unavailability  of reward.  A 5-s  inter-trial interval separated  adjacent  trials. Each  session  was
terminated  after 30 min or 70 response  trials, whichever  came  first.  An animal  stayed  on this
task  until he reached  a performance  criterion of 80%  or greater  for two out of three  sessions.
After each  daily test  session,  all equipment  was  thoroughly  cleaned  using Odormute  (R.C. Steele
Co., Brockport,  NY), a detergent  containing  enzymes  to remove  olfactory cues  left behind  by the
mouse.
C) Series of Attention Tasks
The mice  progressed  through  four attention  tasks  which were  identical  in concept  to the
visual discrimination  task  but in which various  cue  parameters  were  modified to place  greater
and  2, the  cue  duration  was  shortened  to 3 demands  on attention. Briefly, in Attention Tasks
and  2 sec,  respectively. The mice were tested on these  two tasks for 8 and 15 sessions,
respectively.  In Attention Task 3, the interval between trial onset and cue presentation varied
randomly between 0, 2, and 4 s. These variable pre-cue delays were added to a constant "tum-
around time" of 1  s, an interval provided on all trials to allow the mouse time to turn around and
face the response  ports following  trial initiation  in the dipper alcove.  Cue illumination  duration
was constant at 1  s. If the mouse made a nose  poke prior to cue presentation, the trial was
terminated, and a premature response  was tallied.  This task was administered for 20 sessions.  In
Attention Task 4, the pre-cue delay also varied between 0, 2, and 4 s, and in addition, cue
duration varied across  trials between 0.6, 0.8, and 1.0 s. This task was administered for 20
sessions.
D) Surprise  Reward  Omission  (SRO)  Task
This task  was  identical  to Attention  Task  3 except  that the  reward  was  omitted  on 20%
of the  correct  responses.  For these  RO trials, the alcove  door was  not raised  after  the correct:3 Assessment  of the Effects of Perinatal Choline Treatment
response,  and  no reward  was  provided. The mice were  tested  for 20 sessions  on this task.  Based
on our prior findings that  Ts65Dn  mice  exhibit a heightened  emotional  response  to committing
an  error (Driscoll et aI.,  2004),  it was  hypothesized  that they  might also  exhibit a heightened
reaction  to the omission  of an  expected  reward.
E) Types  of errors
Three  types  of errors  were  distinguished  in the four attention  tasks  (Figure  2): (1)
premature  responses,  (2) incorrect  responses,  and  (3) omission  errors. Premature  responses
occurred  when  the mouse  made  a nose  poke  before  the  cue  was  presented;  these  responses
terminated  the trial.  Inaccurate  responses  were  scored  when  the mouse  waited  to respond  until
after  the cue  was  presented  but made  a nose  poke  into a port that was  not illuminated. Omission
errors  were  recorded  when  the mouse  failed to respond  to any  port within 5 s of cue  onset,
indicative  of missing  the visual cue.
Video data and Analvsis Procedures
Each  of the 20 sessions  on the SRO  task  was  recorded  on a VHS tape. Sessions  1 and  2
of this task  were  coded  for this thesis. Various  behaviors  (defmed  below) were  coded  on a PC
using  a program  writte~n  Visual Basic  developed  specifically  for this task. It was  hypothesized
that all groups  would exhibit behavioral  signs  of heightened  arousal  following a correct  trial on
which the reward  was  omitted,  and  that this arousal  would be greater  for the  un  supplemented
Ts65Dn  mice  than  for controls. Furthermore  it was  hypothesized  that the early  choline
supplementation  would ameliorate  this impairment  i? arousal  regulation.
and  2 will be coded  twice for each  mouse,  once  using  a program  designed  to Sessions
quantify  how active  the mouse  is (tenned  the "hyperactivity' program),  and  another  time using  a
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(e.g.,  grooming,  wall-climbing, exploring,  jumping), termed  the "behavior"  program. To date,
these  two sessions  have  been  coded  once  for all animals  (0 =  46) using  the hyperactivity
program;  we plan to code  each  session  again  in the near  future,  using  the 'behavior"  program.
Only the results  of the hyperactivity  analysis  will be included  in this thesis.
A) Hyperactivity  coding
The screen  had  the same  schematic  as  a testing  chamber.  It was  divided into 4 quadrants
(upper  right, lower right, upper  left, lower left), two on each  side  of the box so  that the position
of the mouse  was  noted  at all times.  The left side  included  the  response  ports,  whereas  the right
side  included  the alcove  and  the dipper.  The coder  also  recorded  the start  of each  trial (initiation),
the type  of response  (inaccurate,  correct,  omission,  premature),  and  whether  the reward  was
provided  or not, using  additional  information  provided  by the infrared  LEDs placed  outside  the
chamber  within view of the  camera.  The duration  of the animal  in a particular  quadrant,  the
movement  of the animal,  and  the number  of square  crossings  were  also  noted.
B) Reliability
Both sessions  were  coded  by a single  investigator  who was  blinded  to the animals'
genotype  and  treatment.  Before  coding  the sessions  presented  in this thesis,  the coder  practiced
with other  taped  sessions  until a high level of accuracy  was  achieved.  Eight animals  were
1 of the SRO  task randomly  selected  to be coded  to verify intra-rater  reliability.  Session  10  and
were  coded  twice for each  of the eight animals. Reliability was  determined  by correlating  the
first coding  cycle with the second  coding  cycle. Video coding  of the actual  data  commenced
only after  Pearson  correlation  coefficients  for all dependent  measures  were  equal  to or greater
than .90 for the final practice sessions.
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Statistical  analysis  of the videotape  coding  data  and  the automated  performance  data  was
perfonned  using  the Statistical  Analysis  System  (SAS,  Version  8.2; SAS Institute,  Cary,  NC) on
a Cornell University mainframe  computer.  The automated  performance  measures  were  analyzed
using  PROC  GLIMMIX  program,  a generalized  linear mixed models  procedure  for conducting
repeated  measures  analyses  of variance  with non-normal  data.  The following variables  were
included  in the statistical  models:  genotype,  prestimulus  delay,  and  outcome  of previous  trial
(correct,  incorrect,  or SRO).  Each  session  block consisted  of 5 sessions,  thus  dividing the 20
sessions  into four blocks. The dependent  measures  included:  percent  correct  (the  percentage  of
total response  trials in which the animal  made  a correct  response),  percent  inaccurate  response,
percent  premature  responses,  percent  omission  errors,  percent  non-trials,  and  mean  alcove
latency. The models  used  for these  analyses  included  the above  variables  plus treatment  group
~Ts65Dn,  Ts65Dn  Choline,  2N, 2N Choline). The videotape  data  were  analyzed  in this same
way.
Percent  non-trials  were  analyzed  using  nonparametric  techniques  because  the data  were  not
normally distributed. Daily body weights  for each  animal  of the four treatment  groups  were
compared  using  an analysis  of variance  (ANDV  A).  The fIrst and  last  testing  sessions  for each
animal  was  used  as  the within groups  variable  and  group  was  the  between  subjects  variable.
RESULTS
Although  these  mice were  tested  with the visual discrimination  task  and  the series  of attention
tasks,  this thesis  only included  the results  of the SRO  task.  A total of 46 male  mice  contributed
data  to this study.  Of the 55 original animals,  nine were  excluded  during  the study  for the
following reasons:  four developed  kidney stones  (3 choline  controls  and 1 Ts65Dn),  one  was
found to have  retinal degeneration choline  control), and  another  four mice  died from unknownAssessment  of the Effects of Perinatal Choline Treatment  16
causes  (3 Ts65Dn  and 1 control). Thus,  the [mal sample  sizes  for the four groups  were: 10
Ts65Dn  mice supplemented  with choline, 11  Ts65Dn  mice not supplemented  with choline, 16
littermate  controls  supplemented  with choline,  and  9 control mice not supplemented  with
choline.
Body weight
Body weight did not differ significantly among  the four groups  (F (3,41)=2.67,  p >0.05)
SRO Task
Non  trials
The four groups  did not differ significantly  in the percentage  of nontrials,  defined  as  the trials on
which the  mouse  did not make  an  initiation nosepoke  into the dipper  alcove  at trial onset  (F (3,
42) =2.09, P =0.116).
Percent  Correct
The percent  correct  measure  was  defined  as  the as  the  percent  of correct  responses  over
the total number  of trials. The analysis  of percent  correct  responses  across  the 20 sessions  on the
SRO  Task  revealed  a significant  effect of session-block  (F (3. 435) = 3.97.  p= 0.008)  reflecting
the fact that all groups improved across  the 4 session-blocks (5 sessions  per block). A main
effect of treatment group (F (3. 42.2) =  6',34.  p= 0.001) was also seen.  As seen  in Figure 1, the
unsupplemented  ON group  perfonned  significantly  worse  than  both the  choline-supplemented
2N mice (p= 0.0007), and the unsupplemented  2N mice (j><O.OOO  1 The early choline  treatment
offered  a significant  benefit  to the  trisomic mice: The  choline-supplemented  trisomic mice
performed  significantly  better  than  their un  supplemented  counterparts  (p= 0.029),  and  did not
differ significantly from either  the  unsupplemented  2N mice (p =  0.106)  or the choline-.7 Assessment  of the Effects of Perinatal Choline Treatment
supplemented  2N mice (p =  0.236). In this task,  the  choline  supplementation  did not affect  the
performance of the 2N mice (p = 0.692).
The main  effect of previous  trial outcome  (F (2,334) =21.89, p<O.OOOI)  was  also
significant,  as  was  the interaction  of treatnient  and  previous  trial outcome  (F (6, 334) = 2.27;  P
=0.036),  indicating  that the  relationship  between  the treatment  groups  varied  as  a function of the
outcome  of the  previous  trial. This interaction  reflected  the fact that,  whereas  the
unsupplemented  trisomic mice  were  impaired  relative  to both groups  of 2N mice regardless  of
prior trial outcome  (all p's < 0.005),  the  benefit  of the  perinatal  choline  supplementation  varied
by prior trial outcome.  As depicted  in Figure  2, for trials following either  an  error or a reward
omission,  the supplemented  trisomic mice  did not differ from either  group  of 2N controls,  and
perfOmled  significantly  better  than  the  unsupplemented  trisomic mice (p=O.OO8,  for trials
following an  error; p=O.O  I, for trials following an SRO).  In contrast,  for trials following a correct
response,  the difference  between  the supplemented  DN group  and  the unsupplemented  Dn group
was  only borderline  significant.  The supplemented  DN group  performed  significantly worse  than
the unsupplemented  2N group  (p=O.O36);  they did not differ, however,  from the supplemented
2N group.
The analysis  of percent  correct  also  revealed  a significant  effect of pre-cue  delay  (F (2,
434) = 12. 1, p<O.OOOI),  as well as a significant interaction of treatment and delay (F (6, 434) =
2.30. p=O.033; see  Figure 3).  This latter interaction reflected the fact that the impairment of the
unsupplemented  trisomic mice (relative to the 2N controls), although seen  at all pre-cue delays
(p's < 0.0001), was most pronounced on trials with a 0 s delay prior to cue presentation (see
Figure 3). This pattern may indicate that the unsupplemented  trisomic mice had particular
difficulty  engaging and focusing attention immediately at trial onset. The perinatal cholineAssessment  of the Effects of Perinatal Choline Treatment  18
supplementation was very effective in alleviating the attentional dysfunction of the trisomic
mice, as they did not differ  from either group of 2N at any pre-cue delay, and they were superior
to the unsupplemented  trisomic mice at the 0 (p =  0.009) and 2 (p =0.046) sec delays, a trend
also  seen  at the  4 s delay  (p =  0.098).
Omission  Errors
The analysis  of percent  of omission  errors  revealed  a significant  effect of pre-cue  delay
(F (2,320)=  31.66, p<O.OOOI),  reflecting the fact that, overall, omission error rate was
significantly  higher  on trials with a 0 sec  pre-cue  delay  than  on those  with either  a 2 sec  (p <
These  latter  two conditions  did not differ significantly. 0.001)  or 4 sec  (p < 0.001)  delay.
The omission error analysis also revealed significant effects of treatment group (F (3, 41)
=  723,  p= 0.0005), previous trial outcome (F (2,320) =  12.82, p<O.OOOI),  and an interaction of
treatment group and previous trial outcome (F (6,320) =  2.24,  p= 0.039;  see  Figure  4). This
interaction  reflected  the fact that the  pattern  of performance  as  a function of previous  trial
outcome  varied  slightly for the four treatment  groups.  However,  the basic  relationships  between
the treatment  groups  were  similar regardless  of prior trial outcome.  For this measure,  regardless
of prior trial outcome,  the unsupplemented  trisomic mice  committed  significantly more  omission
errors  than  both groups  of 2N mice,  and  the perinatal  choline  supplementation  was  ineffective
for the trisomic mice.  They did not differ from the unsupplemented  trisomic mice and  performed
significantly  worse  than  the 2N controls  (see  Figure  4 for p values). Finally, the  perinatal
choline  supplementation  also  did not affect  percent  omission  errors  for the 2N mice.
Premature  Responses
The analysis  of percent  premature  responses  revealed  an  effect of previous  trial outcome
(F (2,80.5)=19.7,  P <0.0001),  reflecting  the fact that  in general  mice had  more  premature  errorsAssessment  of the Effects of Perinatal Choline Treatment  19
when  the  previous  trial outcome  was  incorrect  than  on trials  following a correct  response  or a
reward  omission.  However,  neither  the treatment  effect (F (3, 43.2) =  0.15,  P =0.931),  nor the
interaction  of treatment  and  previous  trial outcome  (F(6,80.5)=  1.80,  P =0. 110)  was  significant.
Inaccurate  responses
The analysis  of percent  inaccurate  responses  revealed  a significant  main  effect of
previous  trial outcome  (F(2, 80.1) =  8.30,  p= 0.0005).  This reflected  the fact that overall the
percent  inaccurate  responses  was  higher  when  the previous  trial outcome  was  incorrect  than
when it was correct (p=O.OOO2)  or SRO (p=O.0041);  these latter two conditions did not differ
(p=O.809).  The treatment  effect was  not significant  (F(3,  41)= 1.66,  p=O.l90),  nor was  there  a
significant  interaction  of treatment  and  previous  trial outcome  (F(6, 80.1)=1.25,  p= 0.2887).
Alcove Latency
was  defined  as  the amount  of time elapsed  between  opening  of the Alcove latency  (AL
dipper  alcove  door at trial onset  and  the  time that the mouse  made  a nosepoke  response  in the
alcove  to initiate the  trial. The analysis  of mean  AL revealed  a main  effect of trial block (F (2,
1095) =  36.91, p<O.OOOl),  reflecting the fact that AL  increased  across  the three blocks of trials
within each  testing  session  (Figure  5).
In addition,  this analysis  revealed  main  effects  of previous  trial outcome  (F(2, 1094)=
6.30, p=O.OO2)  and treatment group (F(3, 40) =  5.44, p=O.OO3),  as well as an interaction of
treatment  and  previous  trial outcome  (F(6, 1094)  =  2.60,  p= 0.017;  see  Figure  7). The mean  AL
of the  unsupplemented  trisomic mice  was  significantly  longer  than  that of both groups  of 2N
mice  regardless  of the outcome  of the prior trial. The early  choline  treatment  of the  trisomic
mice  was  beneficial  in that the supplemented  trisomic mice did not differ from either  group  of
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omission  (p =  0797). Consequently,  for trials that followed an  error,  their activity level per trial
was  significantly higher  than  the supplemented  trisomic mice  (p= 0.0301),  the supplemented  2N
(p =  0.04),  and  the unsupplemented  2N mice (p= 0.0207).  As hypothesized,  choline
supplementation  alleviated  this heightened  activity in response  to an  error: the supplemented  Dn
mice were  not significantly  different than  either  the 2N or supplemented  2N mice regardless  of
prior trial outcome  (all p's >0.51).  The 2N groups  did not differ from each  other  regardless  of the
previous  trial outcome.  None  of the groups  showed  any significant  increase  in hyperactivity  after
an SRO  trial.
DISCUSSION
Attentional  Dysfunction  in Ts65Dn  mice
The present  results  demonstrate  that the unsupplemented  Ts65Dn  mice have  significant
attentionaI  dysfunction,  consistent  with our prior study  (Driscoll et aI.,  2004). They performed
more  poorly than  the 2N littermate  controls  on the SRO  task,  as  well as  all four attention  tasks
that  preceded  this task.  The fact that they  did not differ from the 2N mice on the initial visual
discrimination  task  (results  presented  in Moon et aI., 2006)  indicates  that they were  not impaired
in basic  associative  ability. Their intaCt  performance on this visual discrimination  task also
demonstrates  that their impaired performance on the attention tasks (including the SRO task) was
not due to ,low motivation, poor visual acuity, or a reduced understanding of the basic rules of the
tasks or impAirment in the motor demands  of the tasks. The absence  of group differences in the
This pattern  of rate of non-trials further suggests  that the groups did not differ in motivation.
results suggests  that the impaired performance of the trisomic mice in the SRO task was due to
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This inference  is supported  by the  results  of the analyses  of the various  specific  types  of
errors  in the series  of five attention  tasks  (including  the SRO  task). Because  the unsupplemented
trisomic mice  did not differ from the 2N mice in the rate  of premature  responses,  their impaired
performance  is not likely the result  of impulsivity or impaired  inhibitory control. Rather  the
trisomic mice had  a much  higher  rate  of omission  errors  than  the 2N mice,  and  also  a smaller,  but
not significant,  increase  in the rate  of inaccurate  responses.  The increase  of these  types  of errors
implies that  the trisomic mice were  less  attentive  than  the controls,  and  more  likely to miss  the
presentation  of the  brief visual cues.
The random  omission  of an  expected  reward  did not significantly  affect the performance
(percent  correct)  of any  of the mice. However,  the increased  alcove  latencies  for the
un  supplemented  trisomic mice after either  an  error or reward  omission  (relative  to a correct
response)  suggests  increased  emotional  reactivity in the trisomic mice.  These  animals  were  more
They were  the only affected  by the  unavailability  of reward  than  the  other  three  groups  of mice,
group  to show  an increase  in AL after an  error and  SRO  relative  to a correct;  the other  groups
showed  the opposite  pattern;  i.e., the longest  AL after a rewarded  correct  response.  The increased
alcove  latencies  after a correct  response  for all the other  groups  was  probably  due  to grooming
behavior  that is typically seen  in mice after they  consume  food. The increased  AL following an
error and  SRO  seen  in the un  supplemented  trisomic mice may  be,  due  to stereotypic  jumping and
grooming,  based  on the  resul.ts  of our prior study  (Driscoll et aI.,  2004). In this study,  the
trisomic mice exhibited  these  behaviors  specifically  following an  error,  not following a correct
response,  indicating  impaIred  regulation  of arousal  or emotion  produced  by committing an  error.
T~e  coding  of the behaviors  of the mice  in the SRO  task,  currently  in progress,  will provide  a test
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Choline Supplementation  Ameliorates Attentional  Dysfunction
The group  differences  for several  performance  measures  (percent  correct,  omission
errors,  and  alcove  latencies)  demonstrate  that increasing  choline  intake  during a short  period  of
time during early development  can  significantly improve  attentional  functioning  of adult  Ts65Dn
mice. Based  on the  percent  correct  measure,  the trisomic mice supplemented  with choline  early
in life performed  as  well as  the 2N controls  and  significantly  better  than  the unsupplemented
Ts65Dn  mice. Choline  supplementation  appears  to alleviate  the attentional  deficits seen  in the
The normalization  of Ts65Dn  group  and  normalize  performance  to that of the  control groups
the percent  correct  score  appears  to reflect a decrease  in both omission  errors  and  inaccurate
responses.  although  the group  comparisons  for these  specific  error types  did not always  reveal
significant  group  differences.  It appears  that  the significant  group  differences  seen  for percent
correct  reflect a summation  of the effects  on both error types.
A benefit  of the early choline  supplementation  was  also  apparent  from the alcove  latency
data.  As noted  above,  for the unsupplemented  trisomic mice,  mean  AL showed  a trend  of being
longer  for trials following an  error or an  SRO  (relative  to a correct  response)  whereas  the
opposite  pattern  was  seen  for the other  three  groups. This pattern  suggests  that the  Ts65Dn  mice
were  more  affected  by the unavailability  of reward  than  the  other  three  groups  of mice.
Importantly  the choline  supplemented  trisomic mice showed  the same  pattern  as  the  controls.
These  mice  had  the highest  latencies  after  a correct  response,  much  like the 2N mice,  indicating  a
nonnalization  of the  emotiona,l  response  to an  error or reward  omission.  As noted  above,  the
ongoing  analysis  of the  videotapes  will allow a test  of the hypothesis  that the longer  AL of the
untreated  trisomic after  an  error or SRO  was  due  to stereotypical  grooming  and  jumping, and  that
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Lastly, providing excess  choline  during  early development  did not significantly improve
the  perfonnance  of the 2N control mice  in this SRO  task.  This is does  not necessarily  contradict
previous  studies  for two reasons.  First, earlier  studies  showing  choline  supplementation  benefits
in 2N mice have  tested  various  other  septo-hippocampal  and  cortical cognitive functions  besides
attention.  In fact, this is only the second  study,  after  Mohler et al. (2001)  that specifically  tested
the  effects  of choline  supplementation  in attentional  functions  of normal  mice.  This was  also  the
first time an SRO  task  was  used  to evaluate  attentional  functions  in animal  models  of Down
Syndrome.  Secondly.  previous  studies  have  also  shown  a greater  effect of choline
supplementation  in aged  animals.  Since  our animals  were  fairly young  at testing  (11-12  months),
comparison  of these  2N mice  to the older animals  would not be accurate.  Due  to these  two
reasons,  we do not believe  that the data  from this SRO  task  contradicts  earlier  studies.
Furthermore,  in attention  task  3, which,was  identical  to this task  except  without reward
omission,  the supplemented  2N mice  performed  significantly  better  than  unsupplemented
controls  during the early portions  of the task.  These  results  are  presented  in Moon et at. (2006)
but are  not included  as  a part  of this thesis,  which only focused  on the SRO  task.  The  results
from attention  task  3 indicate  an  effect of the early choline  treatment  on the learning  ability of
the  controls. But the SRO  task  did not involve new  learning  which is probably  why there  was  no
beneficial  effect of choline  for the 2N mice in this task.
CONCLUSIONS  AND IMPUCA TIONS
The  present  study  tested  the  efficacy of a novel  therapy  for Down syndrome  and
The results  of Alzheimer's  disease,  namely  providing excess  choline  during early development.
this study  demonstrate  that  early supplementation  of the diet with choline  significantly  improves
attentional  function  of Ts65Dn  mice,  offering the exciting possibility that this type  of nutritionalAssessment  of the Effects of Perinatal Choline Treatment  25
intervention  might provide  an  effective  means  of improving cognitive  functioning  of individuals
with DS, as  well as  a means  of improving cognitive  functioning  in the population  at large.  These
findings suggest  that  current  dietary  guidelines  for choline,  based  on preventing  liver damage
(lnst. Merl., Natl. Acad. Sci. USA. 1998),  may  need  to be modified.  It appears  that higher  levels
of choline  intake  may  be needed  for optimal  brain function.
The neural  bases  of this benefit  of the  early choline  supplementation  are  not known,  but
we propose  that  choline  acts  to alter  the development  and/or  vulnerability of cholinergic  basal
forebrain  neurons.  Most likely the beneficial  effects  on attention  reflect  increased  viability of the
cholinergic  neurons  in the nucleus  basalis,  one  part of the  basal  forebrain. These  cholinergic
neurons  innervate  frontal cortex  and  play an  important  role in the  modulation  of attentional
function (Mohler et al., 2001). This hypothesis  is being  tested  in ongoing  studies,  involving
stereological  counting  of cholinergic  neurons  in the  basal  forebrain  of supplemented  vs.
un  supplemented  trisomic and  2N rtllce.
We look forward to learning  more  about  the  neural  bases  of the  beneficial  effects  of the
early choline  supplementationThe ongoing  coding  of the behaviors  of the mice should  shed
additiona1light  on the  reaction  of the mice  to reward  omission  and  errors,  information  which will
test  the  hypothesis  that the  early intervention  normalized  the heightened  emotional  reactivity of
the trisomic mice.  Future  stud~s  are  needed  to investigate  the  basis  of improvement  and
detemline  the optimal level of choline  supplementation
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Figure 1. Percent correct as a function of session  block
Although  there  was  a main  effect of treatment  a main  effect  of session  block, the treatment  and  session  block was  not
significant.  However,  this figure delineates  the overall improvement  across  session  block for the supplemented  Dn
mice.  These  mice  performed  significantly  better  than  their un  supplemented  counterparts,  and  did not differ significantly
from either  of the 2N groups.b c
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Figure 2. Percent  correct as  a function of previous response  outcome
* p= 0.0010  for Incorrect  previous  response  vs. Correct  previous  response
** p= 0.0079  for Incorrect  previous  response  vs. SRO  previous  response
a p =  0.0007  for 2N vs. Dn for Incorrect  previous  response
b  p< 0.0001  for 2N vs. Dn for Correct  previous  response
cp= 0.0005  for 2N vs. Dn for SRO  previous  responsep = 0.011
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Figure 5. Alcove Latency as  a function of previous trial outcome
a p = 0.002  for 2N vs. Dn for Incorrect  previous  response
b  p= 0.0063  for 2N vs. Dn for Correct  previous  response
C p= 0.0002  for 2N  vs.  Dn for SRO  previous  response3.1
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Figure  6. Activity  level as a function  of previous trial  outcome
* p= 0.0213 for Incorrect previous response  vs. Correct previous response  in Dn group